Average Co-Inventor Count = 4.08
ph-index = 6
The patent ph-index is calculated by counting the number of publications for which an author has been cited by other authors at least that same number of times.
Company Filing History:
1. Exelixis, Inc. (13 from 173 patents)
2. University of California (5 from 15,458 patents)
3. Chevron Research & Technology Company (5 from 251 patents)
4. Symphony Evolution, Inc. (4 from 10 patents)
5. Imperial Chemical Industries Limited (3 from 3,840 patents)
6. Atlasmedx, Inc. (3 from 3 patents)
7. Zeneca Limited (2 from 854 patents)
8. Other (1 from 832,680 patents)
9. Rescue Therapeutics, Inc. (1 from 1 patent)
10. Rascal Therapeutics, Inc. (1 from 1 patent)
33 patents:
1. 12227482 - Compounds and compositions for the treatment of cancer
2. 12145925 - Phthalazine derivatives as inhibitors of PARP1, PARP2, and/or tubulin useful for the treatment of cancer
3. 11597699 - MEK inhibitors and methods of their use
4. 11560356 - Compounds and compositions for the treatment of cancer
5. 11072600 - Phthalazine derivatives as inhibitors of PARP1, PARP2, and/or tubulin useful for the treatment of cancer
6. 10640493 - Phthalazine derivatives as inhibitors of PARP1, PARP2, and/or tubulin useful for the treatment of cancer
7. 10266518 - Solid dosage formulations of substituted quinazoline receptor-type kinase modulators and methods of use thereof
8. 9796704 - Substituted quinazolines as receptor-type kinase inhibitors
9. 9359332 - Processes for the preparation of substituted quinazolines
10. 8697737 - Raf modulators and methods of use
11. 8658654 - Receptor-type kinase modulators and methods of use
12. 8648066 - Benzoxazepines as inhibitors of PI3K/mTOR and methods of their use and manufacture
13. 8637499 - Benzoxazepines as inhibitors of PI3K/mTOR and methods of their use and manufacture
14. 8362002 - Azetidines as MEK inhibitors for the treatment of proliferative diseases
15. 8101625 - Pyrimidinones as Casein Kinase II (CK2) modulators